Integration of albumin-bilirubin (ALBI) score into Barcelona Clinic Liver Cancer (BCLC) system for hepatocellular carcinoma-Reference-Cited by-同舟云学术

Integration of albumin-bilirubin (ALBI) score into Barcelona Clinic Liver Cancer (BCLC) system for hepatocellular carcinoma

Published:2016-07 Issue:7 Volume:31 Page:1300-1306
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Chan Anthony W H¹,Kumada Takshi²,Toyoda Hidenori²,Tada Toshifumi²,Chong Charing C N³,Mo Frankie K F⁴,Yeo Winnie⁴,Johnson Philip J⁵,Lai Paul B S²⁵,Chan Anthony T C⁴,To Ka-Fai¹⁶⁷,Chan Stephen L⁴⁶

Affiliation:

1. Department of Anatomical and Cellular Pathology, State Key Laboratory in Oncology in South China, Prince of Wales Hospital; The Chinese University of Hong Kong; Hong kong

2. Department of Gastroenterology Ogaki Municipal Hospital; Ogaki Japan

3. Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery; The Chinese University of Hong Kong; Hong kong

4. Department of Clinical Oncology, State Key Laboratory in Oncology in South China, Prince of Wales Hospital; The Chinese University of Hong Kong; Hong kong

5. Department of Molecular and Clinical Cancer Medicine; University of Liverpool Liverpool; UK

6. Institute of Digestive Disease, Partner State Key Laboratory of Digestive Disease; The Chinese University of Hong Kong; Hong kong

7. Li Ka Shing Institute of Health Sciences, Sir YK Pao Centre for Cancer; The Chinese University of Hong Kong; Hong Kong

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.13291/fullpdf

Reference24 articles.

1. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients;The Cancer of the Liver Italian Program (CLIP) investigators;Hepatology,1998

2. Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score;Kudo;Hepatology,2004

3. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma;European Association for the Study of the Liver, European Organisation For Research and Treatment of Cancer;J. Hepatol.,2012

4. American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update;Bruix;Hepatology,2011

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma;Clinical and Molecular Hepatology;2024-07-01

2. Relationships between CD147 expression, tumor-infiltrating lymphocytes, and oncostatin M in hepatocellular carcinoma;2024-06-07

3. Albumin–bilirubin grade as a predictor of survival in hepatocellular carcinoma patients with thrombocytopenia;World Journal of Gastrointestinal Oncology;2024-05-15

4. Association of easy albumin-bilirubin score with increased mortality in adult trauma patients;Frontiers in Surgery;2024-04-24

5. Potential involvement of oncostatin M in the immunosuppressive tumor immune microenvironment in hepatocellular carcinoma with vessels encapsulating tumor clusters;Hepatology Research;2023-11-29